Brigham Buhler

And then on the back end, you billionaires can worry about how you're going to profiteer off it.

Yeah, ketamine's a sword that cuts both ways too. I think that ketamine, well, so the way we were using it is as a topical. When applied topically, there is no physiological high. And so as a topical to treat orthopedic pain, it's phenomenal. It has a really, really high success rate. It has no chance of abuse or diversion. You can't get addicted to it because it's topical.

Yeah, ketamine's a sword that cuts both ways too. I think that ketamine, well, so the way we were using it is as a topical. When applied topically, there is no physiological high. And so as a topical to treat orthopedic pain, it's phenomenal. It has a really, really high success rate. It has no chance of abuse or diversion. You can't get addicted to it because it's topical.

Yeah, ketamine's a sword that cuts both ways too. I think that ketamine, well, so the way we were using it is as a topical. When applied topically, there is no physiological high. And so as a topical to treat orthopedic pain, it's phenomenal. It has a really, really high success rate. It has no chance of abuse or diversion. You can't get addicted to it because it's topical.

You're not getting a high. Now, it's being used for anxiety and depression now more and more. And the challenge with that is we perpetuate this problem. Anywhere there's money, there will be bad players. And so candidly, like ketamine has kind of swung towards almost the wild west right now where you've got clinics everywhere administering ketamine.

You're not getting a high. Now, it's being used for anxiety and depression now more and more. And the challenge with that is we perpetuate this problem. Anywhere there's money, there will be bad players. And so candidly, like ketamine has kind of swung towards almost the wild west right now where you've got clinics everywhere administering ketamine.

You're not getting a high. Now, it's being used for anxiety and depression now more and more. And the challenge with that is we perpetuate this problem. Anywhere there's money, there will be bad players. And so candidly, like ketamine has kind of swung towards almost the wild west right now where you've got clinics everywhere administering ketamine.

Some of them may not be good, you know, and there's so much money in it.

Some of them may not be good, you know, and there's so much money in it.

Some of them may not be good, you know, and there's so much money in it.

that they're flying in the gray and so i do worry about that it's the issue isn't the arrow it's the archer i do believe that ketamine is a valuable tool in the tool belt to help people but there are a lot of clinics abusing it and probably over utilizing it and using it just to generate revenue which is unfortunate but this is the same problem we see time and time again with anything it's what we see with the glp-1s it's what we see with antidepressants it's what we see with anything that can generate a lot of revenue

that they're flying in the gray and so i do worry about that it's the issue isn't the arrow it's the archer i do believe that ketamine is a valuable tool in the tool belt to help people but there are a lot of clinics abusing it and probably over utilizing it and using it just to generate revenue which is unfortunate but this is the same problem we see time and time again with anything it's what we see with the glp-1s it's what we see with antidepressants it's what we see with anything that can generate a lot of revenue

that they're flying in the gray and so i do worry about that it's the issue isn't the arrow it's the archer i do believe that ketamine is a valuable tool in the tool belt to help people but there are a lot of clinics abusing it and probably over utilizing it and using it just to generate revenue which is unfortunate but this is the same problem we see time and time again with anything it's what we see with the glp-1s it's what we see with antidepressants it's what we see with anything that can generate a lot of revenue

it becomes overprescribed, overutilized, and abused.

it becomes overprescribed, overutilized, and abused.

it becomes overprescribed, overutilized, and abused.

I think the biggest is that they are going to go after the PBMs. Supposedly Bobby is digging into the pharmacy benefit managers and Trump and a lot of the conservatives and the left are on board to go after the PBMs. I think it's something they universally agree on is to fix that.

I think the biggest is that they are going to go after the PBMs. Supposedly Bobby is digging into the pharmacy benefit managers and Trump and a lot of the conservatives and the left are on board to go after the PBMs. I think it's something they universally agree on is to fix that.

I think the biggest is that they are going to go after the PBMs. Supposedly Bobby is digging into the pharmacy benefit managers and Trump and a lot of the conservatives and the left are on board to go after the PBMs. I think it's something they universally agree on is to fix that.

There is a movement at the Department of Defense separate from the FDA to try to work to implement psychedelics and potentially stem cells, which are more investigatory medicine right now by the FDA. They're not FDA approved, but there is an opportunity to do something big with the Department of Defense. That would be the biggest opportunity.